Harmon K.G. Asif I.M. Klossner D. et al.

Incidence of sudden cardiac death in National collegiate athletic association athletes.

Circulation. 123: 1594-1600Myerburg R. Estes III, N.A.M. Fontaine J.M. et al.

36th Bethesda conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities - task force 10: automated external defibrillators.

J Am Coll Cardiol. 45: 1369-1371Corrado D. Basso C. Rizzoli G. et al.

Does sports activity enhance the risk of sudden death in adolescents and young adults?.

J Am Coll Cardiol. 42: 1959-19632015 IoM. Strategies to improve cardiac arrest survival: a time to act. The National Academies Press, Washington, DCMaron B. Udelson J.E. Bonow R.O. et al.

Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis.

Circulation. 132: e273-e280Zipes D. Link M.S. Ackerman M.J. et al.

Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 9: arrhythmia and conduction defects: a scientific statement from the American heart association and American College of cardiology.

Circulation. 132: e315-e325McAllister D. Motamedi A.R. Hame S.L. et al.

Quality of life assessment in elite collegiate athletes.

Am J Sports Med. 29: 806-810Rahman B. Macciocca I. Sahhar M. et al.

Adolescents with implantable cardioverter defibrillators: a patient and parent Perspective.

Pacing Clin Electrophysiol. 35: 62-72Lampert R. Cannom D. Olshansky B.

Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of herat rhythm society members.

J Cardiovasc Electrophysiol. 17: 11-15Lampert R. Olshansky B. Heidbuchel H. et al.

Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry.

Circulation. 127: 2021-2030Lampert R. Olshansky B. Heidbuchel H. et al.

Safety of sports for athletes with implantable cardioverter-defbrillators: long-term results of a prospective multinational registry.

Circulation. 135: 2310-2312Providencia R. Kramer D.B. Pimenta D. et al.

Transvenous implantable cardioverter-defibrillator (ICD) lead performance: a meta-analysis of Observational studies.

J Am Heart Assoc. 4Link M. Sullivan R.M. Olshansky B. et al.

Implantable cardioverter defibrillator lead survival in athletic patients.

Circ Arrhythmia Electrophysiol. 14NCAA banned Substances. () ()Saarel E. Law I. Berul C.I. et al.

Safety of sports for young patients with implantable cardioverter-defibrillators: long-term results of the multinational ICD sports registry.

Circ Arrhythmia Electrophysiol. 11: e006305Heidbuchel H. Willems R. Jordaens L. et al.

Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: results from the European cohort.

Eur J Prev Cardiol. 26: 764-775James C. Bhonsale A. Tichnell C. et al.

Exercise increases age-related Penetrance and arrhythmic risk in arrhthmogenic right ventricular dysplasia/cardiomyopathy associated desmosomal mutation carriers.

J Am Coll Cardiol. 62Ruwald A.-C. Marcus F. Estes III, et al.

Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy.

Eur Heart J. 36: 1735-1743Ommen S. Mital S. Burke M.A. et al.

AHA/ACC clinical practice guideline: 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy.

Circulation. 142: e588-e631Konhilas J. Watson P.A. Maass A. et al.

Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy.

Circ Res. 98: 540-548Johnson J.N. Ackerman Michael J.

Return to play? Athletes with congenital long QT syndrome.

Br J Sports Med. 47: 28-33Ostby S. Bos J.M. Owen H.J. et al.

Competitive sports participation in patients with catecholaminergic polymorphic ventricular tachycardia: a single center's early experience.

JACC Clin Electrophysiol. 2: 253-262Kurtzwald-Josefson E. Hochhauser E.K. Guy P.E. et al.

Exercise training improves cardiac function and attenuates arrhythmia in CPVT mice.

J Appl Physiol. 113: 1677-1683Manotheepan R. Saberniak J. Danielsen T.K. et al.

Effects of Individualized exercise training in patients with catecholaminergic polymorphic ventricular tachycardia type 1.

Am J Cardiol. 113: 1829-1833Kim J. Malhotra R. Chiampas G. et al.

Cardiac arrest during long-distance running races.

N Engl J Med. 366: 130-140Baggish A. Battle R.W. Beckerman J.G. et al.

Sports cardiology: core curriculum for providing cardiovascular care to competitive athletes and highly active people.

J Am Coll Cardiol. 70: 1902-1918Wilkoff B. Hess M. Young J. et al.

Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac Resynchronization therapy patients.

J Cardiovasc Electrophysiol. 15: 1002-1009

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients Resucitated from Near-fatal ventricular arrhythmias.

N Engl J Med. 337: 1576-1583A

Canadian implantable defibrillator study (CIDS)A Randomized trial of the implantable cardioverter defibrillator against amiodarone.

Circulation. 101: 1297-1302Ruwald M. Ruwald A.-C. Johanse J.B. et al.

Temporal incidence of appropriate and inappropriate therapy and mortality in secondary prevention ICD patients by cardiac diagnosis.

JACC Clin Electrophysiol. 7: 781-792Maron B. Zipes D.P. Kovacs R.J.

Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Preamble, Principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology.

Circulation. 132: e256-e261Ackerman M. Zipes D.P. Kovacs R.J. et al.

Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 10: the cardiac channelopathies.

Circulation. 132: e326-e329Heidbuchel H. Arbelo E. D'Ascenzi F. et al.

Recommendations for participation in lesiure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part 2: ventricular arrhythmias, channelopathies and implantable defibrillators.

Eur Soc Cardiol. 23: 147-148Pelliccia A. Sharma S. Gati S. et al.

2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease.

Eur Soc Cardiol. 42: 17-96

Updated recommendations for athletes with heart disease.

Annu Rev Med. 69: 177-189Naik A. Kallen M.A. Walder A. et al.

Improving hypertension control in diabetes mellitus: the effects of collaborative and proactive health communication.

Circulation. 117: 1361-1368Wilson S.R. Strub P. Buist A.S. et al.

And the better outcomes of asthma treatment (BOAT) study group. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma.

Am J Respir Crit Care Med. 181: 566-577Stacey D. Légaré F. Col N.F. et al.

Decision aids for people facing health treatment or screening decisions.

Cochrane Database Syst Rev. : CD001431Shapero K. Gier Chad et al.

Experiences of athletes with arrhythmogenic cardiac conditions in returning to play.

Heart Rhythm, Nash D. Lee H.-R. Janson C. et al.

Video game ventricular tachycardia: the "Fortnite" phenomenon.

Heart Rhythm Case Rep. 6: 313-317Alkharaza A. Al-Harbi M. El-sokkari I. et al.

The effect of revascularization on mortality and risk of ventricular arrhythmia in patients with ischemic cardiomyopathy.

BMC Cardiovasc Disord. 20De Ferrari G. Dusi V. Spazzolini C. et al.

Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation.

Circulation. 131: 2185-2193Moss A. Schuger C. Beck C.A. et al.

Reduction in inappropriate therapy and mortality through ICD programming.

N Engl J Med. 367: 2275-2283Kutyifa V. Daubert J.P. Schuger C. et al.

Novel ICD programming and inappropriate ICD therapy in CRT-D versus ICD patients: a MADID-RIT sub-study.

Circ Arrhythmia Electrophysiol. 9Olshansky B. Atteya G. Cannom D. et al.

Competitive athletes with implantable cardioverter–defibrillators—how to program? Data from the implantable cardioverter–defibrillator sports registry.

Heart Rhythm. 16: 581-587Slotwiner D. Varma N. Akar J.G. et al.

HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices.

Heart Rhythm. 12: e69-e100Knops R. Nordkamp O. Delnoy P.P.H.M. et al.

Subcutaneous or transvenous defibrillator therapy.

N Engl J Med. 383: 526-536Schneider A. Burkhart H.M. Ackerman M.J. et al.

Minimally invasive epicardial implantable cardioverter-defibrillator placement for infants and children: an effective alternative to the transvenous approach.

Heart Rhythm. 13: 1905-1912Parsons J. Anderson S.A. Casa D.J. et al.

Preventing catastrophic injury and death in collegiate athletes: Interassociation recommendations endorsed by 13 medical and sports medicine Organisations.

J Athletic Train. 54: 843-851